- Report
- September 2026
- 266 Pages
Global
From €5283EUR$5,850USD£4,527GBP
- Report
- September 2026
- 262 Pages
Global
From €5283EUR$5,850USD£4,527GBP
- Report
- September 2026
- 218 Pages
Global
From €5283EUR$5,850USD£4,527GBP
- Report
- September 2026
- 174 Pages
Global
From €5283EUR$5,850USD£4,527GBP
- Report
- September 2026
- 349 Pages
Global
From €5283EUR$5,850USD£4,527GBP
- Report
- September 2026
- 392 Pages
Global
From €5283EUR$5,850USD£4,527GBP
- Report
- September 2026
- 224 Pages
Global
From €5283EUR$5,850USD£4,527GBP
- Report
- September 2026
- 495 Pages
Global
From €5283EUR$5,850USD£4,527GBP
- Report
- September 2026
- 182 Pages
Global
From €5283EUR$5,850USD£4,527GBP
- Report
- September 2026
- 482 Pages
Global
From €5283EUR$5,850USD£4,527GBP
- Report
- September 2026
- 200 Pages
Global
From €5283EUR$5,850USD£4,527GBP
- Report
- September 2026
- 262 Pages
Global
From €5283EUR$5,850USD£4,527GBP
- Report
- September 2026
- 219 Pages
Global
From €5283EUR$5,850USD£4,527GBP
- Report
- September 2026
- 617 Pages
Global
From €5283EUR$5,850USD£4,527GBP
- Report
- September 2026
- 368 Pages
Global
From €5283EUR$5,850USD£4,527GBP
- Report
- September 2026
- 462 Pages
Global
From €5283EUR$5,850USD£4,527GBP
- Report
- January 2026
- 186 Pages
Global
From €3202EUR$3,545USD£2,743GBP
€3557EUR$3,939USD£3,048GBP
- Report
- January 2026
- 193 Pages
Global
From €3202EUR$3,545USD£2,743GBP
€3557EUR$3,939USD£3,048GBP
- Report
- January 2026
- 181 Pages
Global
From €3202EUR$3,545USD£2,743GBP
€3557EUR$3,939USD£3,048GBP
- Report
- January 2026
- 180 Pages
Global
From €3202EUR$3,545USD£2,743GBP
€3557EUR$3,939USD£3,048GBP

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments.
The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more